These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 29861332)

  • 1. Long-term clinical outcomes of permanent-polymer everolimus-eluting stent implantation following rotational atherectomy for severely calcified de novo coronary lesions: Results of a 22-center study (Tokyo-MD PCI Study).
    Otaki Y; Ashikaga T; Sasaoka T; Kurihara K; Yoshikawa S; Isobe M;
    Cardiovasc Revasc Med; 2019 Feb; 20(2):120-125. PubMed ID: 29861332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term clinical outcome of rotational atherectomy followed by drug-eluting stent implantation in complex calcified coronary lesions.
    Abdel-Wahab M; Baev R; Dieker P; Kassner G; Khattab AA; Toelg R; Sulimov D; Geist V; Richardt G
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):285-91. PubMed ID: 22431433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chronic kidney disease on long-term clinical outcomes of everolimus-eluting stent implantation: A subanalysis of the Tokyo-MD PCI registry.
    Miyazaki T; Ashikaga T; Asano M; Sasaoka T; Kurihara K; Yoshikawa S; Isobe M;
    Catheter Cardiovasc Interv; 2019 Jul; 94(1):E9-E16. PubMed ID: 30714680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Speed Rotational Atherectomy Versus Modified Balloons Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions.
    Abdel-Wahab M; Toelg R; Byrne RA; Geist V; El-Mawardy M; Allali A; Rheude T; Robinson DR; Abdelghani M; Sulimov DS; Kastrati A; Richardt G
    Circ Cardiovasc Interv; 2018 Oct; 11(10):e007415. PubMed ID: 30354632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and predictors of early and late target lesion revascularization after everolimus-eluting stent implantation in unselected patients in japan.
    Kurihara K; Ashikaga T; Sasaoka T; Yoshikawa S; Isobe M;
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):78-86. PubMed ID: 28295926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: Two-year clinical outcome of the randomized ROTAXUS trial.
    de Waha S; Allali A; Büttner HJ; Toelg R; Geist V; Neumann FJ; Khattab AA; Richardt G; Abdel-Wahab M
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):691-700. PubMed ID: 26525804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orbital atherectomy for treating de novo, severely calcified coronary lesions: 3-year results of the pivotal ORBIT II trial.
    Lee M; Généreux P; Shlofmitz R; Phillipson D; Anose BM; Martinsen BJ; Himmelstein SI; Chambers JW
    Cardiovasc Revasc Med; 2017 Jun; 18(4):261-264. PubMed ID: 28162989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
    Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease.
    Kufner S; Joner M; Thannheimer A; Hoppmann P; Ibrahim T; Mayer K; Cassese S; Laugwitz KL; Schunkert H; Kastrati A; Byrne RA;
    Circulation; 2019 Jan; 139(3):325-333. PubMed ID: 30586724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial.
    Kelly CR; Teirstein PS; Meredith IT; Farah B; Dubois CL; Feldman RL; Dens J; Hagiwara N; Rabinowitz A; Carrié D; Pompili V; Bouchard A; Saito S; Allocco DJ; Dawkins KD; Stone GW
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2392-2400. PubMed ID: 29217001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.
    Généreux P; Bettinger N; Redfors B; Lee AC; Kim CY; Lee MS; Shlofmitz RA; Moses JW; Stone GW; Chambers JW
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):369-77. PubMed ID: 27084293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary Revascularization.
    Yamaji K; Zanchin T; Zanchin C; Stortecky S; Koskinas KC; Hunziker L; Praz F; Blöchlinger S; Moro C; Moschovitis A; Seiler C; Valgimigli M; Billinger M; Pilgrim T; Heg D; Windecker S; Räber L
    Circ Cardiovasc Interv; 2018 Sep; 11(9):e006741. PubMed ID: 30354590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcomes after coronary artery bypass graft versus everolimus-eluting stent implantation in chronic hemodialysis patients.
    Kumada Y; Ishii H; Aoyama T; Kamoi D; Sakakibara T; Umemoto N; Ito R; Takahashi H; Murohara T
    Coron Artery Dis; 2018 Sep; 29(6):489-494. PubMed ID: 29668554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Everolimus Eluting Stents in Patients with Diabetes Mellitus and Chronic Kidney Disease: Insights from the TUXEDO Trial.
    Bangalore S; Abhaichand R; Mullasari A; Jain R; Chand RKP; Arambam P; Kaul U
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1075-1080. PubMed ID: 31036397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent).
    Vlachojannis GJ; Smits PC; Hofma SH; Togni M; Vázquez N; Valdés M; Voudris V; Slagboom T; Goy JJ; den Heijer P; van der Ent M
    JACC Cardiovasc Interv; 2017 Jun; 10(12):1215-1221. PubMed ID: 28579236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital Atherectomy for the Treatment of Long (≥25-40 mm) Severely Calcified Coronary Lesions: ORBIT II Sub-Analysis.
    Kumar G; Shin EY; Sachdeva R; Shlofmitz E; Behrens AN; Martinsen BJ; Chambers JW
    Cardiovasc Revasc Med; 2020 Feb; 21(2):164-170. PubMed ID: 32014391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer-Generation Drug-Eluting Stents.
    Hemetsberger R; Abdelghani M; Toelg R; Mankerious N; Allali A; Garcia-Garcia HM; Windecker S; Lefèvre T; Saito S; Slagboom T; Kandzari D; Koolen J; Waksman R; Richardt G
    J Am Heart Assoc; 2021 Jun; 10(12):e019815. PubMed ID: 34056911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of total stent length after cobalt chromium everolimus-eluting stent implantation on 3-year clinical outcomes.
    Hiromasa T; Kuramitsu S; Shinozaki T; Jinnouchi H; Morinaga T; Kobayashi Y; Domei T; Soga Y; Shirai S; Ando K
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):207-216. PubMed ID: 26910036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes after Atherectomy Treatment of Severely Calcified Coronary Bifurcation Lesions: A Single Center Experience.
    Chambers JW; Warner C; Cortez J; Behrens AN; Wrede DT; Martinsen BJ
    Cardiovasc Revasc Med; 2019 Jul; 20(7):569-572. PubMed ID: 30201481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.